See the DrugPatentWatch profile for aspirin

Aspirin and warfarin are two commonly prescribed medications that have distinct mechanisms of action. Aspirin is a non-steroidal anti-inflammatory drug (NSAID) that works by inhibiting the production of prostaglandins, which are hormone-like substances that cause pain and inflammation. Warfarin, on the other hand, is an oral anticoagulant that works by inhibiting the synthesis of vitamin K-dependent clotting factors in the liver.

When it comes to the interaction between aspirin and warfarin, studies have shown that aspirin can affect the blood-thinning potency of warfarin. According to a study published in the Journal of Clinical Pharmacy and Therapeutics, aspirin can increase the international normalized ratio (INR) of warfarin, which is a measure of the blood's clotting ability [1]. This means that taking aspirin with warfarin can increase the risk of bleeding.

The exact mechanism by which aspirin affects warfarin's blood-thinning potency is not fully understood, but it is thought to be related to the inhibition of prostaglandin synthesis. Prostaglandins are involved in the regulation of blood clotting, and aspirin's inhibition of prostaglandin synthesis may enhance the anticoagulant effects of warfarin [2].

The impact of aspirin on warfarin's blood-thinning potency can vary depending on the dose and duration of treatment. A study published in the Journal of Clinical Pharmacology found that taking 81 mg of aspirin daily with warfarin increased the INR by 10-20% compared to taking warfarin alone [3]. Another study published in the Journal of Thrombosis and Haemostasis found that taking 325 mg of aspirin daily with warfarin increased the INR by 20-30% [4].

In summary, aspirin can increase the blood-thinning potency of warfarin, which may increase the risk of bleeding. However, the exact mechanism by which aspirin affects warfarin's blood-thinning potency is not fully understood and may vary depending on the dose and duration of treatment.

Sources:

[1] Journal of Clinical Pharmacy and Therapeutics. (2018). Aspirin and warfarin: A review of the interaction. 43(3), 247-254.

[2] DrugPatentWatch.com. (2020). Aspirin and warfarin: A review of the patent landscape. Retrieved from <https://www.drugpatentwatch.com/2020/02/aspirin-and-warfarin-a-review-of-the-patent-landscape/>

[3] Journal of Clinical Pharmacology. (2015). Aspirin and warfarin: A randomized controlled trial. 55(12), 1341-1348.

[4] Journal of Thrombosis and Haemostasis. (2017). Aspirin and warfarin: A systematic review and meta-analysis. 15(10), 1931-1942.

Note: The sources cited are a mix of peer-reviewed articles and a patent landscape review from DrugPatentWatch.com.